Skip to main content
. 2022 Nov 25;101(47):e31426. doi: 10.1097/MD.0000000000031426

Table 13.

Adverse events after treatment.

EPIAO® (N = 99) EPREX® (N = 101) Statistics P value
Instance N Rate (%) Instance N Rate (%)
AEs 144 51 51.52 187 57 56.44 0.4873 .48
Mild 74 32 32.32 73 34 33.66 0.0406 .84
Moderate 59 25 25.25 95 31 30.69 0.1915 .39
Severe 10 10 10.10 19 18 17.82 2.4753 .11